Global Phase 3 Clinical Ops Director - Hybrid

Maze Therapeutics, Inc.

South San Francisco (CA)

Sur place

USD 232 000 - 283 000

Plein temps

14 jours+

Une candidature complète en une minute

Un CV et une lettre de motivation personnalisés, prêts à envoyer.

Passez les filtres ATS

Résumé du poste

Maze Therapeutics in the San Francisco Bay Area seeks a Director of Clinical Operations to lead a global pivotal Phase 3 program in chronic kidney disease. You will translate development strategy into executable plans, oversee a cross‑functional study team, and ensure quality, speed, and inspection readiness across the study lifecycle.

You will manage CROs, vendors, and the internal study execution team, driving risk management, data integrity, and regulatory compliance while aligning resources

Qualifications

  • Bachelor’s degree in a scientific or health‑related field.
  • 10–12+ years of clinical operations experience, including study leadership of Phase I–III trials.
  • Demonstrated success as the end‑to‑end operational lead for a complex large global Phase 3 study.

Responsabilités

  • Lead global Phase 3 study execution from protocol development through enrollment, database lock, and inspection readiness.
  • Oversee CRO, vendor, and site strategies with governance, performance metrics, and risk management.
  • Maintain accountability for a large global study budget including forecasting and variance analysis.
  • Ensure data quality, regulatory readiness, and adherence to SOPs, ICH‑GCP, and global regulatory requirements.
  • Collaborate with QA and Oversight Director on compliance strategy and continuous improvement.

Connaissances

Clinical operations leadership
Budget management
Cross-functional collaboration
Regulatory knowledge
Vendor management
Team development

Formation

Bachelor's degree in scientific/health field

Outils

GCP/compliance tools
TMF management
CRO governance

Description du poste

Maze Therapeutics in the San Francisco Bay Area seeks a Director of Clinical Operations to lead a global pivotal Phase 3 program in chronic kidney disease. You will translate development strategy into executable plans, oversee a cross‑functional study team, and ensure quality, speed, and inspection readiness across the study lifecycle.

You will manage CROs, vendors, and the internal study execution team, driving risk management, data integrity, and regulatory compliance while aligning resources

Obtenez votre examen gratuit et confidentiel de votre CV.

ou faites glisser et déposez votre fichier ici.

Similar jobs

Postes similaires à comparer

Director, Clinical Operations
Director, Clinical Operations

Maze Therapeutics, Inc. • South San Francisco (CA)

Sur place
USD 232 000 - 283 000
Global Phase 3 Clinical Operations Director
Global Phase 3 Clinical Operations Director

UroGen Pharma, Inc. • États-Unis

Sur place
USD 180 000 - 230 000
Medical
Dental
Vision
+3
Global Phase 3 Clinical Operations Director
Global Phase 3 Clinical Operations Director

UroGen Pharma, Inc. • Princeton (NJ)

Sur place
USD 180 000 - 250 000
Medical
Dental
Vision
+3
Global Senior Director, Clinical Operations - Phase 3
Global Senior Director, Clinical Operations - Phase 3

Odyssey Therapeutics, Inc. • États-Unis

À distance
USD 220 000 - 300 000
Director, Study Lead (ClinOps) San Diego, California
Director, Study Lead (ClinOps) San Diego, California

cAMPfield Therapeutics, Inc. • Massachusetts

Sur place
USD 180 000 - 260 000
Global Phase 3 Study Lead - Clinical Program Manager
Global Phase 3 Study Lead - Clinical Program Manager

Planet Pharma • South San Francisco (CA)

Sur place
USD 190 000 - 230 000
Global Phase 2/3 Hematology Clinical Operations Director
Global Phase 2/3 Hematology Clinical Operations Director

Disc Medicine • Watertown (MA)

Hybride
USD 160 000 - 230 000
Clinical Trial Manager – Phase II CKD Trials
Clinical Trial Manager – Phase II CKD Trials

Maze Therapeutics, Inc. • South San Francisco (CA)

Hybride
USD 143 000 - 175 000
Equity incentive plan
401(k) with employer match
Paid holidays and PTO
Global Clinical Development Director - Phase 3
Global Clinical Development Director - Phase 3

Odyssey Therapeutics, Inc. • Boston (MA)

Hybride
USD 177 000 - 221 000
Director of Field Medical & Scientific Leadership
Director of Field Medical & Scientific Leadership

Maze Therapeutics • États-Unis

Sur place
USD 205 000 - 295 000
Medical, dental, and vision insurance
Equity incentive plan
401(k) with employer match
+1